Interventional Cardiology Devices Market Study Report Based on Company Profile , Trends , Top Key Vendor , Future Growth And Outlook 2028
interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year. Coronary heart disease is the leading heart disease type that, in 2017, accounted for the deaths of 365,914 individuals in the US. Interventional cardiology devices deliver several benefits, including reduced chances of scar occurrence, reduced surgery complexity and time, and decreased pain. Additionally, rising incidence of cardiovascular diseases result in an increase in healthcare expenditure, which in turn, is driving revenue growth of the interventional cardiology devices market. According to the Centers for Disease Control and Prevention, heart attacks account for over USD 320.00 Billion in yearly healthcare expenditure and lost productivity, and this figure is expected to reach USD 818.00 Billion in 2030.
Global Interventional Cardiology Devices Market that provides an extensive analysis of the Interventional Cardiology Devices market and industry overview with regards to market size, market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments, and a comprehensive analysis of the impact of COVID-19 pandemic on the growth of the Interventional Cardiology Devices market. The report aims to offer a clear understanding of the market with respect to the manufacturers, suppliers, vendors, distributors, and key companies involved in the market. The report has been formulated through extensive primary and secondary research along with verified and reliable data obtained from industry experts and professionals. The key findings from the report have been sorted into charts, figures, tables, and other pictorial representations.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/570
The global Interventional Cardiology Devices market is expected to reach USD 26.84 billion in 2028 from its valuation of USD 13.72 billion in 2020 at a CAGR of 8.7% during the forecast period. Rapid technological advancements and economic growth are key factors expected to drive market growth over the forecast period. The report further provides a comprehensive analysis of the competitive landscape and provides a complete coverage with regards to company’s profiles, product portfolio, revenue generation, financial standing and market position.
Top Companies Operating in the Interventional Cardiology Devices Market and Profiled in the Report are:
Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH.
It further offers a comprehensive coverage of the strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product launches, brand promotions, and partnerships, among others. Key strategic alliances for product development and advancements is expected to add traction to market growth going ahead. The report also covers an in-depth analysis of the key competitors of the market along with their growth strategies and business expansion plans.
Regional analysis of the Interventional Cardiology Devices market includes analysis of the production and consumption ratio, supply and demand dynamics, regional trends and growth drivers, growth prospects, presence of key manufacturers and vendors, and market size and share in key regions such as North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. The report further offers key insights into country wise analysis and major factors driving revenue growth of each regional market.
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/570
Detailed Regional Analysis Covers:
- North America
- Rest of EU
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
- Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Angioplasty Stents
- Angioplasty Balloons
- Structural Heart Devices
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Ambulatory Surgical Centers
Explore Similar Reports offered by Emergen Research: